Use of AliveCor ECG Monitoring to Replicate ECG Lead Recording

Not Applicable

Withdrawn

• Conditions: Arrhythmia
• Interventions: Device: AliveCor Heart Monitor

• Registration Number: NCT04472520
• Lead Sponsor: Mayo Clinic

Brief Summary

The researchers are trying to determine whether the Alivecor device can simulate other electrocardiogram (ECG) leads to record electrical activity.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2020-06-05
• Status Verified: 2020-07
• Study First Submitted QC: 2020-07-10
• Last Update Submitted: 2020-07-10
• Study First Posted: 2020-07-15
• Last Update Posted: 2020-07-15
• Study Start: 2021-01-01
• Primary Completion: 2021-12-31
• Study Completion: 2022-12-31

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Individuals greater than 18 years old getting an ECG

Read More

Exclusion Criteria

• Patients unwilling or unable to provide informed consent

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Subject getting an ECG	AliveCor Heart Monitor	Subjects getting an ECG will have AliveCore tracings obtained in 3 configurations; between right hand and left hand, between left hand and left lower leg (thigh, calf, and foot) and between right hand and left lower leg (thigh, calf, and foot).These configurations will be obtained with the participant lying in bed and in a sitting position.

Primary Outcome Measures

Name	Time	Method
Electrocardiogram (ECG) QT Interval	1 day	The QT interval represents the time of ventricular activity including both depolarization and repolarization. It is measured from the beginning of the QRS complex to the end of the T wave. Normally, the QT interval is 0.36 to 0.44 seconds

Trial Locations

Locations (1)

Mayo Clinic Arizona; 🇺🇸 Phoenix, Arizona, United States